Last reviewed · How we verify

NCT06010550

Validating a Clinical Decision Support Tool for Stratifying Stroke Risk for Dizziness/Vertigo

Status unknown Last updated 29 August 2023
What this trial tests

trial testing Magnetic resonance imaging in Dizziness in 600 participants. Status unknown.

Timeline
1 October 2023
Primary endpoint
31 July 2025
31 December 2025

Quick facts

Lead sponsorChiayi Christian Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment600
Start date1 October 2023
Primary completion31 July 2025
Estimated completion31 December 2025

Drugs / interventions tested

Conditions studied

Sponsor

Chiayi Christian Hospital

Who can join

20 and older, any sex, with Dizziness or Vertigo. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to validate a machine learning model that stratifies the risk of stroke in patients who present to the emergency department with dizziness or vertigo.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Magnetic resonance imaging

Trials testing the same drug.

Other recruiting trials for Dizziness

Currently open trials in the same condition.

Other Chiayi Christian Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06010550.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing